"Melbourne 15 April 2008 – As previously announced by the Company on 11 March 2008, Fulcrum Equity Limited (Fulcrum or the Company) (ASX:FUL) has undertaken discussions with New Medical Enterprises Pty Ltd (NME) in response to its non-binding offer to purchase the non Iridium related assets and liabilities of the Company.
Both parties have agreed to extend the initial review period until 30 April 2008 to allow each party to consider particulars of the offer in greater detail.
Further information will be provided to shareholders and the market as the initial review progresses.
NME is a company associated with Fulcrum’s chairman, Mr Michael Boyd."
-------------------------------------------------------
Will be interesting to see the outcome of this. Ideally (and ethically) NME should buy the health assets at a good price seeing as Boyd obviously sees value in these businesses. Even if the price is enough to cover the debt incurred at least this will leave us with a clean slate and a healthy position moving forward.
1 cent could easily swing back to 4 or 5 cents if the news is good... or it could just fall over :oP
One for the punters.
Add to My Watchlist
What is My Watchlist?
